Literature DB >> 7937753

Characterization of the PP2A alpha gene mutation in okadaic acid-resistant variants of CHO-K1 cells.

H Shima1, H Tohda, S Aonuma, M Nakayasu, A A DePaoli-Roach, T Sugimura, M Nagao.   

Abstract

Okadaic acid (OA)-resistant variants of Chinese hamster ovary cells, clones CHO/OAR6-6 and CHO/OAR2-3, were isolated from a CHO-K1 culture. These variant cells were 17- to 26-fold more resistant to OA than the parental cells. The phosphorylase phosphatase activity of the variant cell extracts was 2- to 4-fold more resistant to OA than that of the parental cells in the presence of inhibitor 2, a specific inhibitor of type 1 protein serine/threonine phosphatase (PP1). Nucleotide sequencing of PP2A alpha (an isotype of PP2A catalytic subunit) cDNA demonstrated that both variants have a T-->G transversion at the first base of codon 269 (805 nt), which results in substitution of glycine for cysteine. We expressed in COS-1 cells a mutant PP2A alpha tagged with the influenza hemagglutinin epitope. The recombinant mutant PP2A alpha protein immunoprecipitated with an anti-influenza hemagglutinin antibody was more resistant than the wild type to OA, their IC50 values being 0.65 nM and 0.15 nM, and their IC80 values being 4.0 nM and 0.45 nM, respectively. The cysteine at residue 269 present only in highly OA-sensitive protein serine/threonine phosphatase catalytic subunit isozymes, PP2A alpha, PP2A beta, and PPX, is suggested to be involved in the binding of OA. CHO/OAR6-6 and CHO/OAR2-3 cells also overexpressed the P-glycoprotein, and the efflux of OA was more rapid. It is suggested that the PP2A alpha mutation in cooperation with a high level of P-glycoprotein makes the CHO-K1 variants highly resistant to OA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937753      PMCID: PMC44793          DOI: 10.1073/pnas.91.20.9267

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

2.  Protein phosphatase-1 and protein phosphatase-2A from rabbit skeletal muscle.

Authors:  P Cohen; S Alemany; B A Hemmings; T J Resink; P Strålfors; H Y Tung
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

3.  Molecular cloning of cDNA for the catalytic subunit of rat liver type 2A protein phosphatase, and detection of high levels of expression of the gene in normal and cancer cells.

Authors:  Y Kitagawa; T Tahira; I Ikeda; K Kikuchi; S Tsuiki; T Sugimura; M Nagao
Journal:  Biochim Biophys Acta       Date:  1988-11-10

4.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

5.  High-efficiency transformation of mammalian cells by plasmid DNA.

Authors:  C Chen; H Okayama
Journal:  Mol Cell Biol       Date:  1987-08       Impact factor: 4.272

6.  Expression and characterization of rat protein phosphatases-1 alpha, -1 gamma 1, -1 gamma 2, and -1 delta.

Authors:  Z Zhang; G Bai; M Shima; S Zhao; M Nagao; E Y Lee
Journal:  Arch Biochem Biophys       Date:  1993-06       Impact factor: 4.013

7.  A mutant of protein phosphatase-1 that exhibits altered toxin sensitivity.

Authors:  Z Zhang; S Zhao; F Long; L Zhang; G Bai; H Shima; M Nagao; E Y Lee
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

Review 8.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

9.  Okadaic acid: an additional non-phorbol-12-tetradecanoate-13-acetate-type tumor promoter.

Authors:  M Suganuma; H Fujiki; H Suguri; S Yoshizawa; M Hirota; M Nakayasu; M Ojika; K Wakamatsu; K Yamada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

10.  PPX, a novel protein serine/threonine phosphatase localized to centrosomes.

Authors:  N D Brewis; A J Street; A R Prescott; P T Cohen
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  10 in total

1.  Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.

Authors:  A Krautheim; P Brechlin; K Becker; M Winkler; H J Steinfelder
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding.

Authors:  H B Huang; A Horiuchi; J Goldberg; P Greengard; A C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.

Authors:  Archna Ravi; Shelly Kaushik; Aarthi Ravichandran; Catherine Qiurong Pan; Boon Chuan Low
Journal:  J Biol Chem       Date:  2014-12-18       Impact factor: 5.157

4.  Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid.

Authors:  H Nakagama; S Kaneko; H Shima; H Inamori; H Fukuda; R Kominami; T Sugimura; M Nagao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

Review 5.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.

Authors:  V Janssens; J Goris
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

6.  Regulation of PRDX1 peroxidase activity by Pin1.

Authors:  Kai Ling Chu; Qiao Jing Lew; Vikneswari Rajasegaran; Jing Ting Kung; Lu Zheng; Qiaoyun Yang; Rachel Shaw; Nge Cheong; Yih-Cherng Liou; Sheng-Hao Chao
Journal:  Cell Cycle       Date:  2013-02-19       Impact factor: 4.534

7.  CREB/TRH pathway in the central nervous system regulates energy expenditure in response to deprivation of an essential amino acid.

Authors:  T Xia; Q Zhang; Y Xiao; C Wang; J Yu; H Liu; B Liu; Y Zhang; S Chen; Y Liu; Y Chen; F Guo
Journal:  Int J Obes (Lond)       Date:  2014-04-15       Impact factor: 5.095

Review 8.  Regulation of Cardiac PKA Signaling by cAMP and Oxidants.

Authors:  Friederike Cuello; Friedrich W Herberg; Konstantina Stathopoulou; Philipp Henning; Simon Diering
Journal:  Antioxidants (Basel)       Date:  2021-04-24

Review 9.  The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.

Authors:  Peter P Ruvolo
Journal:  BBA Clin       Date:  2016-08-03

10.  Paxillin phosphorylation at serine 273 and its effects on Rac, Rho and adhesion dynamics.

Authors:  Kaixi Tang; Colton G Boudreau; Claire M Brown; Anmar Khadra
Journal:  PLoS Comput Biol       Date:  2018-07-05       Impact factor: 4.475

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.